34200 Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices

TABLE 5.—COLLECTION OF INFORMATION REQUIRED BY CURRENT REGULATIONS AND STANDARDS—Continued

PHS Guideline

Section Description of Collection of Information Activity 21 CFR Section (unless otherwisestated)

4.3 Sponsor to keep records of receipt, shipment, and disposition of investigative drug;

investigator to keep records of case histories

312.57 and 312.62(b)

1The ‘‘Public Health Service Policy on Humane Care and Use of Laboratory Animals’’ (http://www.grants.nih.gov/grants/olaw/references/

phspol.htm). 2AAALAC International Rules of Accreditation (http://www.aaalac.org/html/rules.html).

3The NRC’s ‘‘Guide for the Care and Use of Laboratory Animals’’ (1996).

II. Electronic Access

Persons with access to the Internet

may obtain the guideline at http://

www.fda.gov/cber/guidelines.htm.

Dated: May 23, 2000.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

[FR Doc. 00–13340 Filed 5–25–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[FDA 225–99–7000]

Memorandum of Understanding

Between the Food and Drug

Administration, the Centers for

Disease Control and Prevention, the

U.S. Department of Agriculture, the

U.S. Department of Defense, and the

Environmental Protection Agency

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is providing

notice of a memorandum of

understanding (MOU) between FDA, the

Centers for Disease Control and

Prevention, the U.S. Department of

Agriculture, the U.S. Department of

Defense, and the Environmental

Protection Agency. The purpose of the

MOU is to establish an interagency

coordinating committee on animal

production and food health with the

goal of improving animal and public

health.

DATES: The agreement became effective

November 17, 1999.

FOR FURTHER INFORMATION CONTACT:

Robert C. Livingston, Center for

Veterinary Medicine (HFV–1), Food and

Drug Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–5903.

SUPPLEMENTARY INFORMATION: In

accordance with 21 CFR 20.108(c),

which states that all written agreements

and MOU’s between FDA and others

shall be published in the Federal

Register, the agency is publishing notice

of this MOU.

Dated: May 19, 2000.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

The MOU is set forth in its entirety as

follows:

BILLING CODE 4160–01–F

Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices 34201

34202 Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices

Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices 34203

34204 Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices

Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices 34205

34206 Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices

Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices 34207

34208 Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices

Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices 34209

34210 Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices

Federal Register / Vol. 65, No. 103 / Friday, May 26, 2000 / Notices 34211

[FR Doc. 00–13208 Filed 5–25–00; 8:45 am]

BILLING CODE 4160–01–C